TEMOZOLOMIDE
NDC 16571-817, temozolomide, capsule, from Rising Pharma Holdings, Inc..
- Product NDC
- 16571-817
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206309
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16571-817 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TEMOZOLOMIDE20 mg/1
Pharmacologic classes
Alkylating Activity [MoA]; Alkylating Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16571-817-02 | 16571081702 | 20 CAPSULE in 1 BOTTLE (16571-817-02) |
| 16571-817-41 | 16571081741 | 14 CAPSULE in 1 BOTTLE (16571-817-41) |
| 16571-817-51 | 16571081751 | 5 CAPSULE in 1 BOTTLE (16571-817-51) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/70996a9d-4a4f-4ed1-ab07-130486aa14abNADAC price for package 16571081741
GET /v1/drugs/nadac/16571081741NADAC price for package 16571081751
GET /v1/drugs/nadac/16571081751
Use it
Look up 16571-817 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16571-817 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16571-817. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.